Radiation toxicity following busulfan/melphalan high-dose chemotherapy in the EURO-EWING-99-trial: review of GPOH data

Strahlenther Onkol. 2009 Aug:185 Suppl 2:21-2. doi: 10.1007/s00066-009-1009-9.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / toxicity*
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / radiotherapy*
  • Bone Neoplasms / surgery
  • Busulfan / administration & dosage
  • Busulfan / toxicity*
  • Chemotherapy, Adjuvant
  • Child
  • Combined Modality Therapy
  • Cross-Sectional Studies
  • Dactinomycin / administration & dosage
  • Dactinomycin / toxicity
  • Dose-Response Relationship, Drug
  • Germany
  • Humans
  • Ifosfamide / administration & dosage
  • Ifosfamide / toxicity
  • Intestines / radiation effects
  • Lung / radiation effects
  • Melphalan / administration & dosage
  • Melphalan / toxicity*
  • Multicenter Studies as Topic
  • Radiation Injuries / epidemiology*
  • Radiation Injuries / etiology
  • Radiotherapy Dosage
  • Radiotherapy, Adjuvant
  • Randomized Controlled Trials as Topic
  • Registries
  • Retrospective Studies
  • Risk Factors
  • Sarcoma, Ewing / drug therapy*
  • Sarcoma, Ewing / radiotherapy*
  • Sarcoma, Ewing / surgery
  • Spinal Cord / radiation effects
  • Survivors / statistics & numerical data*
  • Vincristine / administration & dosage
  • Vincristine / toxicity

Substances

  • Dactinomycin
  • Vincristine
  • Busulfan
  • Melphalan
  • Ifosfamide